Table 1. Association between MIR17HG expression and clinicopathological characteristics in colon cancer.
Variable | Total (n=60) | Expression of MIR17HG | P | |
---|---|---|---|---|
High (n=37) | Low (n=23) | |||
Age (years) | 0.082 | |||
<65 | 23 | 11 | 12 | |
≥65 | 37 | 26 | 11 | |
Gender | 0.471 | |||
Male | 33 | 19 | 14 | |
Female | 27 | 18 | 9 | |
Location | 0.811 | |||
Right | 22 | 14 | 8 | |
Others | 38 | 23 | 15 | |
pT stage | 0.062 | |||
T1 | 6 | 1 | 5 | |
T2 | 24 | 18 | 6 | |
T3 | 21 | 12 | 9 | |
T4 | 9 | 6 | 3 | |
pN stage | 0.005* | |||
N0 | 29 | 12 | 17 | |
N1 | 12 | 9 | 3 | |
N2 | 19 | 16 | 3 | |
TNM stage | <0.001* | |||
I/II | 25 | 8 | 17 | |
III/IV | 35 | 29 | 6 | |
Differentiation | 0.838 | |||
Well | 32 | 19 | 13 | |
Moderate | 21 | 13 | 8 | |
Poor | 7 | 5 | 2 | |
Vessel invasion | 0.327 | |||
No | 41 | 27 | 14 | |
Yes | 19 | 10 | 9 |
*, P<0.05 represents the P values with significant differences.